SK Biopharmaceuticals Co (XKRX:326030) Short-Term Capital Lease Obligation : ₩6,210 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is SK Biopharmaceuticals Co Short-Term Capital Lease Obligation?

SK Biopharmaceuticals Co's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩6,210 Mil.

SK Biopharmaceuticals Co's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (₩5,754 Mil) to Dec. 2023 (₩7,061 Mil) but then declined from Dec. 2023 (₩7,061 Mil) to Mar. 2024 (₩6,210 Mil).

SK Biopharmaceuticals Co's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (₩5,481 Mil) to Dec. 2022 (₩5,644 Mil) and increased from Dec. 2022 (₩5,644 Mil) to Dec. 2023 (₩7,061 Mil).

SK Biopharmaceuticals Co Short-Term Capital Lease Obligation Historical Data

The historical data trend for SK Biopharmaceuticals Co's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SK Biopharmaceuticals Co Short-Term Capital Lease Obligation Chart

SK Biopharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

3,196.66

4,905.79

5,481.44

5,644.02

7,060.82

SK Biopharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															5,807.76	5,457.11	5,754.09	7,060.82	6,210.16

SK Biopharmaceuticals Co Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

SK Biopharmaceuticals Co Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of SK Biopharmaceuticals Co's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

SK Biopharmaceuticals Co (XKRX:326030) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Biopharmaceuticals Co Ltd (XKRX:326030) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

221, Pangyoyeok-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13494

Website

https://www.skbp.com

SK Biopharmaceuticals Co Ltd is a pharmaceutical company engaged in research and development of new drugs for treatment of central nervous system (CNS) disorders. The company is also researching for the development of drugs to treat brain tumors, including metastatic tumors. It has a Bio Science Research Institute in Pangyo Techno Valley in Gyeonggi Province. Its drugs in pipeline include Cenobamate, Solriamfetol, Carisbamate, Relenopride, SKL13865, SKL20540, SKL-PSY, and SKL24741.

SK Biopharmaceuticals Co (XKRX:326030) Headlines

No Headlines